Torrent Pharmaceuticals Ltd.
Snapshot View

2858.25 -17.25 ▼-0.6%

27 June 2022, 04:01:00 PM
Volume: 1,036

Overview View Details

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.torrentpharma.com
Market Cap 48,364.08 Cr.
Enterprise Value(EV) 52,053.53 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 45.92 Trailing Twelve Months Ending 2022-03
Price-Earning Ratio (PE) 62.24 Trailing Twelve Months Ending 2022-03
Industry PE 29.84 Trailing Twelve Months Ending 2022-03
Book Value / Share 351.79 Trailing Twelve Months Ending 2022-03
Price to Book Value 8.12 Calculated using Price: 2,858.25
Dividend Yield 1.68 Period Ending 2021-03
No. of Shares Subscribed 16.92 Cr. 169,208,720 Shares
FaceValue 5
Company Profile
Torrent Pharmaceuticals has established itself as a major player in the Indian Pharma arena. The company has well segregated marketing divisions, strategically structured on specific therapeutic areas and enjoys dominance in therapeutic segment of cardiovascular (CV), central nervous system (CNS), gastro-intestinal (GI) and women healthcare (WHC). With Unichem's domestic business acquisition, Torrent has entered the list of top pharma firms in the Indian Pharma Market (IPM) and is ranked No 8 in the IPM.

Delivery View Details

Delivered Qty
Traded Qty

Performance View Details

1 Day
-0.60%
1 Week
+3.45%
1 Month
-2.78%
3 Month
+4.17%
6 Month
-9.23%
1 Year
-0.91%
2 Year
+15.61%
5 Year
+141.53%
10 Year
+877.01%
9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%) 33.25 39.94 34.19 57.92 23.80 15.12 9.34 21.47 23.49
Return on Capital Employed (%) 31.66 35.06 26.98 45.63 20.36 13.81 9.75 15.28 17.63
Return on Assets (%) 12.79 15.16 11.71 20.89 10.28 5.81 3.15 7.50 9.20

Balance Sheet View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds 1,422 1,902 2,491 3,494 4,350 4,622 4,724 4,823 5,837 5,953
Non Curr. Liab. 620 927 2,505 1,995 2,303 4,142 3,861 3,299 2,924 2,238
Curr. Liab. 1,711 2,175 2,824 3,285 2,738 5,202 5,165 5,454 4,892 4,415
Minority Int. 0 0 0 0 0 1
Equity & Liab. 3,753 5,004 7,820 8,775 9,392 13,967 13,751 13,577 13,653 12,606
Non Curr. Assets 1,192 1,600 3,768 4,086 4,513 8,705 8,714 8,596 8,130 7,311
Curr. Assets 2,561 3,404 4,051 4,689 4,879 5,262 5,038 4,981 5,523 5,295
Misc. Exp. not W/O
Total Assets 3,753 5,004 7,820 8,775 9,392 13,967 13,751 13,577 13,653 12,606

Profit Loss View Details

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. TTM
Net Sales 3,211 4,185 4,653 6,667 5,816 5,950 7,673 7,939 8,005 8,510
Other Income 43 38 286 229 223 307 64 121 76 195
Total Income 3,255 4,223 4,939 6,896 6,039 6,257 7,736 8,061 8,081 8,705
Total Expenditure -2,519 -3,233 -3,633 -3,937 -4,438 -4,609 -5,696 -5,769 -5,538 -6,074
PBIDT 736 990 1,306 2,959 1,601 1,648 2,040 2,292 2,542 2,631
Interest -34 -59 -175 -184 -206 -308 -504 -451 -358 -258
Depreciation -83 -87 -191 -238 -307 -409 -618 -654 -658 -662
Taxation -147 -180 -189 -610 -155 -253 -125 -162 -274 -449
Exceptional Items -37 -194 -357 -485
PAT 435 664 751 1,733 934 678 436 1,025 1,252 777
Minority Interest -2 0 0 0 0 0 0
Share Associate
Other Related Items
Consolidated Net Profit 433 664 751 1,733 934 678 436 1,025 1,252 777
Adjusted EPS 26 39 44 102 55 40 26 61 74 46

Cash Flow View Details

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 499 153 599 810 2,742 1,009 894 1,798 1,393 2,011
Cash Fr. Inv. -137 -242 -356 -2,162 -838 -787 -4,707 -241 199 -449
Cash Fr. Finan. -193 20 86 1,212 -1,435 -193 3,417 -1,314 -1,549 -1,656
Net Change 169 -68 330 -140 469 29 -395 242 42 -95
Cash & Cash Eqvt 761 687 955 865 1,050 1,068 702 940 662 573

Shareholding Pattern View Details

9 Qtrs 2020-03 (%) 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%)
Promoter 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25 71.25
Public 28.75 28.75 28.75 28.75 28.75 28.75 28.75 28.75 28.75
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 36.49 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details

Fri, 03 Jun 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of Loss of Share Certificates
Tue, 31 May 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement for completion of dispatch of Postal Ballot Notice
Tue, 31 May 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement in respect of the transfer of shares to IEPF

Technical Scans View Details

Mon, 27 Jun 2022
Opening at High Opening at High
Closing Below Previous Low Closing Below Previous Low
Making Higher Highs for 3 days Making Higher Highs for 3 days
Close Within 52 Week High Zone Close Within 52 Week High Zone
Increasing Relative Strength - Sectoral Index Increasing Relative Strength - Sectoral Index

Related Stocks View Details

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 200,572.41 835.95 +1.4%
Divi's Laboratories Ltd. 97,518.56 3,679.05 0.0%
Cipla Ltd. 75,086.75 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. 71,855.08 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. 54,559.09 3,795.45 -1.0%
Gland Pharma Ltd. 43,775.42 2,658.60 +0.6%
Piramal Enterprises Ltd. 39,749.44 1,665.10 +0.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 61.29 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 32.99 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 29.83 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 32.92 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 51.70 3,795.45 -1.0%
Gland Pharma Ltd. Consolidated 2022-03 36.13 2,658.60 +0.6%
Piramal Enterprises Ltd. Consolidated 2022-03 20.64 1,665.10 +0.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 4.18 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2022-03 8.33 3,679.05 0.0%
Cipla Ltd. Consolidated 2022-03 3.60 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 3.74 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 9.68 3,795.45 -1.0%
Gland Pharma Ltd. Consolidated 2022-03 6.12 2,658.60 +0.6%
Piramal Enterprises Ltd. Consolidated 2022-03 1.12 1,665.10 +0.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 0.08 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 0.00 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 0.10 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 0.17 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 0.62 3,795.45 -1.0%
Gland Pharma Ltd. Consolidated 2021-03 0.00 2,658.60 +0.6%
Piramal Enterprises Ltd. Consolidated 2021-03 1.16 1,665.10 +0.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Piramal Enterprises Ltd. Consolidated 2021-03 3.33 1,665.10 +0.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 4.98 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 23.90 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 14.13 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 11.53 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 3.44 3,795.45 -1.0%
Gland Pharma Ltd. Consolidated 2021-03 20.97 2,658.60 +0.6%
Piramal Enterprises Ltd. Consolidated 2021-03 3.33 1,665.10 +0.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 33,498.14 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 6,969.40 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 19,159.59 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 19,047.50 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 10,560.00 3,795.45 -1.0%
Gland Pharma Ltd. Consolidated 2021-03 3,462.88 2,658.60 +0.6%
Piramal Enterprises Ltd. Consolidated 2021-03 12,809.35 1,665.10 +0.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2021-03 2,284.68 835.95 +1.4%
Divi's Laboratories Ltd. Consolidated 2021-03 1,984.29 3,679.05 0.0%
Cipla Ltd. Consolidated 2021-03 2,401.30 932.25 -0.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2021-03 1,903.60 4,317.15 +0.2%
Apollo Hospitals Enterprise Ltd. Consolidated 2021-03 136.00 3,795.45 -1.0%
Gland Pharma Ltd. Consolidated 2021-03 996.96 2,658.60 +0.6%
Piramal Enterprises Ltd. Consolidated 2021-03 1,074.43 1,665.10 +0.8%

FAQ's On Torrent Pharmaceuticals Ltd.

Can I Buy Torrent Pharma Shares now?

What is the Share Price of Torrent Pharma?

What is the Relative Strength Index (RSI) Value of Torrent Pharma?

What is the Market Capital (MCAP) of Torrent Pharma?

What are the key metrics to analyse Torrent Pharma?

What is the Price Performance of Torrent Pharma?